Baby boomers looking to set up their portfolios for a relaxing and rewarding retirement have plenty of factors to consider.

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

Pfizer (NYSE: PFE) has been around for 175 years, but the company's revenue soared to its highest ever only in more recent ...

Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

Pfizer's robust R&D pipeline is expected to drive future growth and offset patent expirations. Read why I maintain my buy ...

In a report released today, Elmar Kraus from DZ BANK AG maintained a Hold rating on Koninklijke Philips N.V. (0LNG – Research Report). The ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

Both in their mid-twenties, the two men set up what was initially a fine chemicals business in a Brooklyn factory, using a loan from Pfizer’s father as capital. The company’s first product ...

Ambrosia Biosciences Inc., a drug-discovery company launched last year, has added Jason Haddock, a former executive with ArcherDX Inc. and Array BioPharma Inc., to its board of directors.

The "Sinusitis Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The sinusitis treatment pipeline analysis provides an overview of recent ...

Fresh from the $43 billion acquisition of antibody-drug conjugate (ADC) specialist Seagen, Pfizer has laid out plans ... That shift could protect the company from some of the price-cutting ...